| Literature DB >> 33364753 |
Carlos Cabrera López1, Enrique Mascarós2, Angel Azpeitia3, Elena Villarrubia4.
Abstract
Background: Diagnostic and treatment strategies for chronic obstructive pulmonary disease (COPD) vary greatly. Despite international efforts to standardize the management of COPD, two-thirds of primary care patients are not diagnosed, treated, or managed according to current evidence-based guidelines, probably because of the difficulty of applying these in routine practice. The aim of this study was to develop a simplified algorithm for diagnosing, treating, and managing COPD in primary care whose consistency, scientific relevance, and applicability to routine clinical practice met approval bct 3y family doctors (FDs) and pulmonologists.Entities:
Keywords: COPD; Delphi technique; consensus; management; primary care; treatment
Mesh:
Year: 2020 PMID: 33364753 PMCID: PMC7751579 DOI: 10.2147/COPD.S281422
Source DB: PubMed Journal: Int J Chron Obstruct Pulmon Dis ISSN: 1176-9106
Figure 1Flow chart of process.
Figure 2Final diagram of the diagnosis of COPD as proposed by the Delphi consensus.
Results of the First Round of the Delphi Process
| Question | No. (%) in Agreement | No. (%) in Agreement | No. (%) in Agreement | Decision Taken |
|---|---|---|---|---|
| Diagnosis | ||||
| Dx1 | 71 (94.7%) | 38 (88.4%) | 109 (92.4%) | Consensus |
| Dx2 | 54 (72%) | 30 (69.8%) | 84 (71.2%) | Pass to round 2 |
| Dx3 | 70 (93.3%) | 32 (74.4%) | 102 (86,4%) | Pass to round 2 |
| Dx4 | 63 (85.2%) | 37 (86%) | 100 (84.7%) | Consensus |
| Dx5 | 69 (92%) | 38 (88.4%) | 107 (90.7%) | Consensus |
| Classification and treatment | ||||
| Tx1 | 67 (89.3%) | 27 (62.8%) | 94 (79.7%) | Pass to round 2 |
| Tx2 | 69 (92%) | 30 (69.8%) | 99 (83.9%) | Pass to round 2 |
| Tx3 | 61 (81.3%) | 41 (95.3%) | 102 (86.4%) | Consensus |
| Tx4 | 59 (78.7%) | 32 (74.4%) | 91 (77.1%) | Pass to round 2 |
| Tx5 | 67 (89.3%) | 39 (90.7%) | 106 (89.8%) | Consensus |
| Tx6 | 70 (93.3%) | 39 (90.7%) | 109 (92.4%) | Consensus |
| Tx7 | 75 (100%) | 42 (97.7%) | 117 (99.2%) | Consensus |
| Tx8 | 74 (98.7%) | 37 (86%) | 111 (94.1%) | Consensus |
| Tx9 | 72 (96%) | 34 (79.1%) | 106 (89.8%) | Consensus |
| Tx10 | 71 (94.7%) | 33 (76.7%) | 104 (88.1%) | Consensus |
| Tx11 | 62 (83.1%) | 35 (83.1%) | 97 (82.2%) | Consensus |
| Tx12 | 40 (53.3%) | 39 (90.7%) | 79 (66.9%) | Pass to round 2 |
| Tx13 | 64 (85.3%) | 41 (95.3%) | 105 (88.9%) | Consensus |
| Tx14 | 67 (89.3%) | 35 (81.4%) | 102 (86.4%) | Consensus |
| General | ||||
| Finally, do you think that the ALGORITHM as a whole is functional and useful for routine primary care practice? | 72 (96%) | 38 (88.4%) | 110 (93.2%) | Consensus |
Results from the Second Round of the Delphi Process
| Question | No. (%) in Agreement | No. (%) in Agreement | No. (%) in Agreement | Decision Taken |
|---|---|---|---|---|
| Diagnosis | ||||
| Dx2 | 72 (97.3%) | 42 (100%) | 114 (98.2%) | Consensus |
| Dx3 | 71 (95.9%) | 40 (95.2%) | 111 (95.7%) | Consensus |
| Classification and treatment | ||||
| Tx1 | 70 (94.6%) | 38 (90%) | 108 (93.1%) | Consensus |
| Tx2 | 69 (93.2%) | 37 (88.1%) | 106 (91.4%) | Consensus |
| Tx4 | 65 (87.8%) | 37 (88.1%) | 102 (96.2%) | Consensus |
| Tx12 | 65 (87.8%) | 28 (66.7%) | 93(80,2%) | Consensus |
| General | ||||
| Overall, do you think that this new algorithm is clear and practical for routine management in primary care? | 70 (94.6%) | 36 (85.7%) | 106 (91.4%) | Consensus |
Figure 3Final diagram of the treatment of COPD as proposed by the Delphi consensus. (A) One month after starting treatment and then every 2–6 months. Assess dyspnea (mMRC) and exacerbations. (B) Check treatment adherence and correct inhaler use, assess other comorbidities, modify treatment if necessary, and schedule next visit. (C) Dyspnea persistence or worsening and/or one severe or two moderate exacerbations. (D) Add ICS for exacerbation, SABA as rescue therapy, systemic antibiotics and/or corticosteroids for acute exacerbation, PDE4 inhibitors for chronic bronchitis and exacerbation, methylxanthines if stability is not achieved despite maximum treatment, and mucolytics/antioxidants for plentiful secretions. Refer to specialist if no improvement or unstable.